• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Medtronic

Medtronic

Medtronic PLC MDT 3 Star

Last Price$76.32Day Change (%)-1.15%
Open Price$77.13Day Change ($)-0.89
Day Range76.32–77.3852-Week Range58.32–79.50

As of Fri 5/29/2015 7:55:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Medtronic MDT Q4 2014 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by, and welcome to the Medtronic Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. Thank you.

  2. Research and Markets: Global Capsule Endoscopes Market 2015 Report with Forecasts to 2019

    Research and Markets: Global Capsule Endoscopes Market 2015 Report with Forecasts to 2019

  3. Super-Wide Moat in the Making at Medtronic

    The device maker's planned acquisition of Covidien will make it a force to be reckoned with.

  4. No Surprises in Medtronic's Fiscal Third Quarter

    The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.

  5. 'Smart money' cools on Alibaba, other themes from hedge-fund portfolios

    'Smart money' cools on Alibaba, other themes from hedge-fund portfolios

  6. Research and Markets: Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecasts for the $289 Billion Market

    Research and Markets: Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecasts for the $289 Billion Market

  7. Research and Markets: Global Hernia Repair Devices and Consumables Market 2013-2020 - Analysis and Forecasts for the 3.9 Billion Market

    Research and Markets: Global Hernia Repair Devices and Consumables Market 2013-2020 - Analysis and Forecasts for the 3.9 Billion Market

  8. Alnylam Files Clinical Trial Application (CTA) for ALN-AAT, an Investigational RNAi Therapeutic for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease)

    Alnylam Files Clinical Trial Application (CTA) for ALN-AAT, an Investigational RNAi Therapeutic for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease)

  9. Research and Markets: Europe Orthobiologics (Bone Graft Substitutes, Bone Allografts, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation) Market 2015 - Forecast to 2019

    Research and Markets: Europe Orthobiologics (Bone Graft Substitutes, Bone Allografts, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation) Market 2015 - Forecast to 2019

  10. Research and Markets: Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021

    Research and Markets: Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.